ViaDerma Inc (VDRM)

[industrialist]

I keep reading this: "“In recent studies, Viabecline has been more than 96% effective in healing diabetic foot ulcers within 4 weeks. This effect is more pronounced in more severe wounds, and the effect is the same whether the wound is infected or not…Our goal is to have Viabecline added to all diabetic foot ulcer treatment protocols.”

If this were even 50% true, this stock would be worth hundreds of millions. It could even have a market cap of a billion, given all the people who need treatment for these ulcers. Yet the market cap hovers around the 10 million mark.

It might be the DR's poster that even states the number of people that have avoided amputation because of this cream. If any of this were even partially true, this stock would soar on these points alone. Something is awfully, awfully wrong. What is the problem? We'll see if this conference poster presentation changes anything. If it doesn't, it's obvious nobody believes the Dr.'s claims.